Development and pilot screen of novel high content assay for down regulators of expression of heterogenous nuclear ribonuclear protein H2
J. Diez, S. Rajendrarao, S. Baajour, P. Sripadhan, T. Spicer, L. Scampavia, D. Minond
The paper develops a high-content screening assay to identify down regulators of hnRNPH2 for melanoma therapy, finding a 0.5% hit rate in a drug library with two validated compounds.
bioRxiv · Oct 5, 2020 · PreprintCancer Biology